Position in REPL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$442,800
New position
Shares Held
40,000
first reported quarter
Ownership
0.042%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#85
of 199 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026KLCM Advisors, Inc. holds $696,695 across 2 Biotechnology names. REPL ranks #1 (63.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REPL |
Replimune Group, Inc.
This page
|
40,000 | $442,800 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
29,000 | $253,895 |
All Filings in REPL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $442,800 | 40,000 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||